Inside Michelle McMurry-Heath’s departure from BIO; This summer’s Covid surge was bad for hospital profits

Michelle McMurry-Heath's abrupt exit from BIO shocked the biotech industry. Here's the inside story of how her departure unfolded. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Inside Michelle McMurry-Heath's departure from BIO: Firings, internal clashes, and a pivotal job review By Rachel Cohrs Alex Hogan/STAT; Source photo: Melissa Lyttle for STAT Michelle McMurry-Heath’s abrupt exit from BIO shocked the biotech industry. Here’s the inside story of how her departure unfolded. Read More STAT+: This summer's Covid surge was bad for hospital profits By Tara Bannow Adobe The summer Covid-19 surge hurt hospital finances, as both HCA Healthcare and Tenet Healthcare posted lower profit and revenue. Read More FDA's vaccines chief sees possibility of more Covid boosters — sooner than he'd like By Helen Branswell Jim Lo Scalzo/Pool via AP Peter Marks thinks it's conceivable that the booster shot people are getting now may not be the last some will need for the coming year. Read More Sponsored Insight by National Consumers League Protect patients' healthcare privacy and genetic data The U.S. Department of Defense recently listed BGI as a Chinese military company operating in the United States. American health information collected by BGI has no legal protection against disclosure to the Chinese government. The healthcare community must ensure patients' health records and genetic data are protected and not used for nefarious purposes, including genetically targeted bioweapons and bio-surveillance. Learn more at protectmypatientdata.com. Medicare is going to cap patients' spending on drugs. But there's no such limit for hospital or doctor bills By Bob Herman Adobe By 2025, Medicare patients will not have to pay more than $2,000 in a year for drugs. But there's no such limit for hospital and other bills. Read More Opinion: Support family caregivers to improve and diversify clinical trials By Sharon Inouye and Jason Resendez Ben Margot/AP The clinical trial enterprise could reap numerous benefits from engaging family caregivers in studies if it engages them from the start. Read More Opinion: Research funding is broken. Using a lottery approach could fix it By Lionel Page and Adrian Barnett Adobe Stock A randomized approach to awarding research funding — a lottery system — could speed the funding process and generate more innovation. Read More Friday, October 21, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser